The COVID-19 pandemic catalyzed unparalleled speed and cross-sector collaboration in the innovation of tools and technologies to address an emerging infectious disease outbreak. Continued innovation and collaboration in rapid development and implementation of new vaccines, therapeutics, and diagnostics is central to future outbreak preparedness. The National Academies Forum on Microbial Threats; Forum on Drug Discovery, Development, and Translation; and the Forum on Medical and Public Health Preparedness for Emergencies and Disasters held a workshop in December 2022 to explore how innovative approaches in research can enhance health systems preparedness and responses to emerging infectious diseases and dangerous pathogens. Workshop participants reflected on critical scientific infrastructure for stakeholder coordination and innovations that can facilitate rapid and effective preparedness and response to emerging infectious disease threats. This Proceedings of a Workshop summarizes the discussions held during the workshop.

Contents

• The National Academies of SCIENCES • ENGINEERING • MEDICINE
• APPLYING LESSONS LEARNED FROM COVID-19 RESEARCH AND DEVELOPMENT TO FUTURE EPIDEMICS WORKSHOP PLANNING COMMITTEE
• FORUM ON MICROBIAL THREATS
• Reviewers
• Acknowledgments
• Acronyms and Abbreviations
• 1. Introduction
  • WORKSHOP OBJECTIVES
  • ORGANIZATION OF THE PROCEEDINGS OF THE WORKSHOP
• 2. Preparedness and Response in the Research Community
  • THE COVID-19 PANDEMIC: LESSONS LEARNED
  • DISCUSSION
• 3. Equitable Scientific Collaborations, Partnerships, and Coordination Within the United States
  • INDUSTRY PERSPECTIVE ON THE COVID-19 RESPONSE
  • ACADEMIC PERSPECTIVE ON THE COVID-19 RESPONSE
  • RESEARCH AND PARTNERSHIP IN COVID-19 VACCINE DEVELOPMENT
  • WASHINGTON STATE GOVERNMENT COVID-19 RESPONSE
  • DISCUSSION
• 4. Equitable Scientific Collaborations, Partnerships, and Coordination on the Global Scale
  • TWIN PILLARS OF GLOBAL VACCINE PARTNERSHIPS: ADDRESSING ACCESS EQUITY AND HESITANCY
  • PANEL REFLECTIONS
  • DISCUSSION
  • EXPANDING GLOBAL COLLABORATION, CAPACITY, AND ENGAGEMENT
• 5. Coordination and Partnering Between Scientific Researchers, Policymakers, and the General Public
  • COMMUNICATION AND VACCINE ACCEPTANCE CONSIDERATIONS
  • COORDINATION AND PARTNERING BETWEEN SCIENTIFIC RESEARCHERS, POLICYMAKERS, AND THE GENERAL PUBLIC
  • DISCUSSION
• 6. Social and Behavioral Considerations for Acceptance and Uptake of Public Health Recommendations
  • CIVIL SOCIETY
  • INDIVIDUAL BEHAVIOR AND IDENTITY
  • COMMUNICATING BIOMEDICAL RESEARCH
  • FULL PANEL DISCUSSION
• 7. Sustainment: Aspects of Leadership and Support
  • SUSTAINING LEADERSHIP FOR PREPAREDNESS AND RESPONSE
  • IMPLEMENTING BARDA'S PANDEMIC PREPAREDNESS AND RESPONSE CAPABILITY
  • BARRIERS TO PANDEMIC PREPAREDNESS
  • DISCUSSION
• 8. A Vision for the Future and Final Synthesis
  • DELIVERING VACCINES FOR EMERGING INFECTIOUS DISEASES: HARNESSING THE POWER OF INNOVATIVE PARTNERSHIPS
  • DISCUSSION
  • FINAL SYNTHESIS
• References
• Appendix A. Workshop Statement of Task
• Appendix B. Public Meeting Agenda

Suggested citation:

National Academies of Sciences, Engineering, and Medicine. 2023. Applying lessons learned from COVID-19 research and development to future epidemics: Proceedings of a workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/27194.

Digital Object Identifier: https://doi.org/10.17226/27194

This publication is available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.

Printed in the United States of America.